Meet Proteona at HCA Asia: 22 Oct. 2020

Single Cell Multi-omics

Mark your calendar for the Human Cell Atlas Asia Meeting 2020

Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology

Dr. Jonathan Scolnick, scientific co-founder of Proteona, will be presenting at the Human Cell Atlas (HCA) Asia Meeting 2020, taking place on 22-23 October.

Dr. Scolnick will discuss new methods in single cell multi-omics research. His talk will be at 3.30pm on Thursday, 22 October, 2020. Mark your calendar now to join us for the scientific discussions.

Check out the HCA Asia Meeting 2020 program here!

Follow Proteona on LinkedIn

For media queries, please contact:

Dr. Andreas Schmidt

About Proteona

Proteona is a precision medicine company in Singapore, Germany, and the US that is pioneering the use of single cell multi-omics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona enables pharmaceutical companies, biotech partners, and clinicians to integrate single cell level precision into their clinical projects. Proteona continues to develop comprehensive, disease-specific single cell databases combining gene expression, protein expression, and mutation information derived from each individual cells as well as drug response data for each sample. Proteona has been selected as a “One to Watch” by Nature Research Spinoff Award and a Winner of Falling Walls Ventures Breakthrough of the Year 2020. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR).